Garvan Institute of Medical Research | GenomeWeb

Garvan Institute of Medical Research

The reference bank is a sub-project of the Sydney Genomics Collaborative, and will be one of the world's largest publicly available genome banks of older healthy individuals. 

The company's Irys genome mapping technology provides researchers with a non-sequencing-based tool that is essential for studying structural variation.

A team from Radboud University in the Netherlands performed a new detailed and transparent cost analysis for sequencing based on both static costs, and factors that may differ from institution to institution.

The Sydney-based genomics center is implementing diagnostic sequencing pipelines and figuring out best practices for incorporating genomics into healthcare.

The current arrangement builds on an existing agreement signed last year that allowed Garvan to use DNAnexus' platform for its genomics activities.

The WGS service will be provided by Genome.One, a new health information company owned by and based at the Garvan Institute of Medical Research in Sydney.

The Garvan Institute of Medical Research's Mark Cowley said his lab has a more than 50 percent diagnostic rate for rare, monogenic diseases.

Under the terms of the agreement, the partners will share de-identified genomic and clinical data as well as explore new opportunities for collaboration.

Australia may take on its own project to sequence 100,000 genomes, according to the PHG Foundation.

Under the agreement, the organizations will work on making genomic information more accessible, meaningful, and usable.

Pages

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.